The projected per capita market size for penicillins and streptomycins in Canada shows a steady increase from $7.71 in 2024 to $8.44 by 2028. Year-on-year growth varies slightly: 3.24% from 2024 to 2025, 2.39% from 2025 to 2026, 1.96% from 2026 to 2027, and 1.56% from 2027 to 2028. The compound annual growth rate (CAGR) over the five-year period is approximately 2.30%. In 2023, the per capita value stood at $7.47.
Future trends to watch for include:
- Potential impacts of new antibiotic resistance strains on demand.
- Regulatory changes in healthcare policies affecting antibiotic usage.
- Advancements in drug formulation and delivery systems.
- Public health initiatives promoting antibiotic stewardship.
